Medical Device Regulatory Requirements in Bosnia and Herzegovina

Regulatory Authority Agency for medicinal products and medical devices
Regulatory Authority Website Link Click Here
Device Classification I, IIa, IIb and III
Medical Device Regulations Medical Device Regulation (Same Regulations for IVD) | Click Here
IVD Classification A,B,C,D
Device Classification Guidelines

PART III - RULES FOR CLASSIFICATION OF MEDICAL DEVICES
TITLE I - GENERAL RULES

| Click Here
Registration Process Article 32 of the regulation tells The procedure for registration of manufacturers of medical devices in the Register)
Registration Timeline 3 months
Conformity Assessment Route

The process of establishing the conformity of the medical device with general and special requirements depends on the classification of the medical device according to the degree of risk, namely:

a) for Class I medical devices - manufacturer itself assesses the compliance of the product with the general and specific requirements and, on their own responsibility, makes a statement or certificate based on that. Exceptions are class I medical devices that are used to measure and sterile products that are adjusted, which are treated as medical devices from class IIa, IIb and III for determining their ability to measure or sterility;


b) for medical devices from class IIa, IIb and III - the competent institution determines the compliance of medical devices with the prescribed general and special requirements, as well as the supervision of the quality assurance system.


Refer Article 37

| Click Here
Technical Documentation Format

The technical documentation that should enable the conformity of the medical device, which contains the following information:


a) a general list of medical devices, design specifications, including standards that are used and the result of the risk analysis;
b) plan's design, description of production processes, description of components and auxiliary parts of the medical device;
c) the responsibility of leading personnel and its competencies during the development of a medical device;
d) methods of monitoring of applied quality system;
e) a description of the methods of sterilization in the case of sterile products and test results;
f) proof that the medical device meets the essential requirements in the case when it is connected to other medical product with the characteristics specified by the manufacturer;
g) clinical data when required in accordance with this Ordinance;
h) labeling and instructions for use.

Requirement of Authorized Representative Yes
Language Requirement instructions for use in a foreign language for products of foreign origin and proposalinstructions in one of the official languages in Bosnia and Herzegovina;
Labeling Requirements

Every medical device that is marketed in Bosnia and Herzegovina should be labeled as such on the outer and the immediate packaging in one of the official languages in BiH and have attached instructions for use.

Refer Artile 38 and 53 for more infomation

| Click Here
Fees for Submission

Article 16 (The costs relating to the registration, amendment and re-registration of medical devices in the register of medical devices)

| Click Here
Post Market Surveillance

The deadlines for reporting of the adverse reactions related to medical devices are:

  • for serious threat to public health: IMMEDIATELY, no later than two days after the manufacturer has become aware of the threat
  • for patient’s death or unexpected serious deterioration of patient’s health condition: IMMEDIATELY, no later than ten days after the manufacturer of the medical device has detected connection between medical device and adverse event;
  • for other adverse reactions: IMMEDIATELY, no later than thirty days after manufacturer of the medical device has established connection between medical device and adverse event
| Click Here
Reportable Incidents
When adverse effects occur, criteria for their registration are the following:
  • That there is suspicion of its connection to medical device;
  • That adverse effect has caused or could cause patient’s death or deterioration of patient’s, user’s or any other person’s health conditions
Additional Information

The marketing of the medicinal product authorization shall be issued for a period of 5 years.

Disclaimer: This website sources information from regulatory authorities and aims for accuracy, but regulations may change without notice. Users are advised to verify details with relevant authorities before making compliance decisions. We are not responsible for errors, omissions, or outdated content.

The above information is last updated on 24/Jun/2025

If you found this helpful, consider supporting by buying me a coffee ☕
Every little bit counts!